From the Guidelines
The main adverse effects of progesterone-only oral contraceptive pills (POPs) include irregular menstrual bleeding, hormonal side effects, and a potential slight increase in the risk of ectopic pregnancy, but they do not significantly increase the risk of blood clots, as supported by the 2020 American College of Rheumatology guideline 1. The most common side effect of POPs is irregular menstrual bleeding, which can manifest as spotting, prolonged bleeding, or amenorrhea, affecting up to 70% of users. Some users may experience hormonal side effects such as headaches, breast tenderness, mood changes, decreased libido, and acne. Additionally, some users may report nausea, although this is less common than with combined hormonal contraceptives, and weight gain, which is typically minimal. POPs can also cause functional ovarian cysts, which are usually asymptomatic and resolve spontaneously. It is essential to note that, unlike estrogen-containing contraceptives, POPs do not significantly increase the risk of blood clots, making them a suitable option for women with risk factors for thromboembolism, as stated in the 2020 guideline 1. However, they may slightly increase the risk of ectopic pregnancy if conception occurs while using POPs, as they can affect fallopian tube motility. The side effect profile varies between different progestin formulations, with newer progestins like desogestrel potentially causing fewer bleeding irregularities but more hormonal side effects. Most side effects are mild and tend to improve after the first few months of use as the body adjusts to the hormone. Key points to consider when prescribing POPs include:
- Irregular menstrual bleeding is the most common side effect
- Hormonal side effects can occur but are typically mild
- No significant increase in the risk of blood clots
- Potential slight increase in the risk of ectopic pregnancy
- Suitable for women with risk factors for thromboembolism, as recommended by the 2020 American College of Rheumatology guideline 1.
From the FDA Drug Label
ADVERSE REACTIONS • Menstrual irregularity is the most frequently reported side effect. • Frequent and irregular bleeding are common, while long duration of bleeding episodes and amenorrhea are less likely. • Headache, breast tenderness, nausea, and dizziness are increased among progestin-only oral contraceptive users in some studies. • Androgenic side effects such as acne, hirsutism, and weight gain occur rarely.
The main adverse effects of progesterone-only oral contraceptive pills (OCPs) are:
- Menstrual irregularity
- Frequent and irregular bleeding
- Headache
- Breast tenderness
- Nausea
- Dizziness
- Androgenic side effects such as:
- Acne
- Hirsutism
- Weight gain 2
From the Research
Adverse Effects of Progesterone-Only Oral Contraceptive Pills (OCPs)
- Menstrual disturbances, which can affect acceptability and lead to poor compliance and higher pregnancy rates 3
- Abnormal uterine bleeding, a common but rarely dangerous side effect of hormonal contraception 4
- Breakthrough bleeding, which usually subsides within a few months, but can persist in some cases 5, 4
- Weight gain, although most studies have found little or no change in weight regardless of formulation 5, 6
- Acne and hirsutism, which can be eliminated or improved by use of OCPs with low androgenic activity 5
- Nausea and breast tenderness, which are primarily estrogen-related effects, but can occur with progesterone-only OCPs as well 5, 6
- Headaches, which are not significantly different among various combined oral contraceptives, but can be affected by switching preparations or using a longer cycle of OC treatment 5, 6
- Mood changes, which are a common, highly subjective complaint, but whose relationship to OC use is hard to assess 5, 6
Management of Adverse Effects
- Counseling and reassurance are often adequate for managing adverse effects, especially during the first few months of use 6, 4
- Switching to a different formulation or preparation can help alleviate some adverse effects, such as acne or headaches 5, 6
- Supplemental estrogen and/or nonsteroidal anti-inflammatory drugs (NSAIDs) can be used to treat abnormal uterine bleeding 4
- Patient education and assessment of medical eligibility can help decrease the chance of unanticipated adverse effects 6